Business fortunes rebounding, Asia Pacific activities heading towards profit. ・Next generation test Cxbladder Triage Plus ...

DUNEDIN, New Zealand, April 12, 2017 /PRNewswire/ -- Pacific Edge is proud to announce that its recent clinical study on Cxbladder Monitor's clinical performance and utility has been published in the ...

DUNEDIN, New Zealand, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Bladder cancer diagnostics provider, Pacific Edge Diagnostics, has been notified by Novitas1 that the LCD: Biomarkers for Oncology (L35396) ...

The agreement with FedMed Inc has been finalised with Pacific Edge's subsidiary in the USA, Pacific Edge Diagnostics USA (PED USA). The agreement provides FedMed's contracted insurance carriers, third ...

Research Shows Pacific Edge’s Cxbladder Detect Outperforms Other Non-Invasive Bladder Cancer Diagnostics Dunedin, NZ and Hershey, PA (May 25, 2015): Newly published research demonstrates that ...

Pacific Edge says a New Zealand study of medical professionals shows they are upbeat about the quality of its bladder cancer test. The Dunedin-based company's Cxbladder product is a non-invasive test ...

Cancer diagnostics company Pacific Edge (NZX, ASX: PEB) welcomes the release of new research supporting the clinical utility of the company's genomic biomarker test Cxbladder Monitor in the ...

Pacific Edge Signs Agreement Extending Commercial Partnership with MidCentral District Health Board, to Encompass All Cxbladder Tests for Application Across the Clinical Pathway Cancer diagnostics ...

Two Christchurch urologists have words of caution about the marketing of a urine test for detection of bladder cancer direct to patients. This week Dunedin biotech Pacific Edge said it would launch an ...

Providers using BxLink can easily access Cxbladder's suite of tests, allowing faster integration of these groundbreaking diagnostics into everyday practice. The platform's advanced capabilities ensure ...